Genes Flashcards

1
Q

RET

A

RET proto-oncogene encodes a receptor tyrosine kinase that binds glial-derived neurotrophic factor (GDNF) and other ligands in the GDNF family and transmits growth and differentiation signals (Chapter 7). Loss-of-function mutations in RET result in intestinal aganglionosis and Hirschsprung disease (Chapter 17). In contrast, in MEN-2A (as well as in MEN-2B), germline mutations constitutively activate the RET receptor, resulting in gain of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

VHL

A

3p25-p26

  • tumor suppressor gene
  • encodes a ubiquitously expressed 4.7-kilobase (kb) messenger ribonucleic acid (mRNA) that encodes 3 alternately spliced exons. The resultant 2 von Hippel-Lindau proteins (pVHL) shuttle between the nucleus and the cytoplasm, where they form a complex with several proteins. At present, this gene is the only gene known to cause von Hippel-Lindau disease.
  • polyubiquination
  • regulation of HIF1a and HIF2a & other hypoxia inducible genes
  • cell cycle control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rb

A

Retinoblastoma

13q14

tumor suppressor gene

blocks exit from G1 in cell cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

p53

A

G1 arrest apoptosis

17p13.1

guardian of the genome

Li-Fraumeni syndrome

most commonly mutated gene in human cancer!

In a normal cell p53 is inactivated by its negative regulator, mdm2. Upon DNA damage or other stresses, various pathways will lead to the dissociation of the p53 and mdm2 complex. Once activated, p53 will induce a cell cycle arrest (at the G1/S regulation point) to allow either repair and survival of the cell or apoptosis to discard the damaged cell. How p53 makes this choice is currently unknown.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

APC

A

adenomatous polyposis coli

aka “deleted in polyposis 2.5 (DP2.5)”

5q21

The APC protein helps control how often a cell divides, how it attaches to other cells within a tissue, or whether a cell moves within or away from a tissue. This protein also helps ensure that the chromosome number in cells produced through cell division is correct. The APC protein accomplishes these tasks mainly through association with other proteins, especially those that are involved in cell attachment and signaling. The activity of one protein in particular, beta-catenin, is controlled by the APC protein (see: Wnt signaling pathway). Regulation of beta-catenin prevents genes that stimulate cell division from being turned on too often and prevents cell overgrowth.

The most common mutation in colon cancer is inactivation of APC. When APC does not have an inactivating mutation, beta catenin does. These mutations can be inherited, or arise sporadically, often as the result of mutations in other genes that produce chromosomal instability. A mutation on APC or β-catenin must be followed by other mutations to become cancerous; however, in carriers of an APC inactivating mutations, the risk of colorectal cancer by age 40 is almost 100%.[2]

Familial adenomatous polyposis (FAP) is caused by mutations in the APC gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NF-1

A

neurofibromin

17q11

prevents cell overgrowth by turning off another protein (called ras) that stimulates cell growth and division

In rare cases, inactivation of one copy of the NF1 gene in each cell increases the risk of developing juvenile myelomonocytic leukemia (JMML).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NF-2

A

neurofibromin 2 (aka merlin or schwannomin)

22q12

mainly made in Schwann cells

Merlin is believed to play a role in controlling cell shape, cell movement, and communication between cells. To carry out these tasks, merlin associates with the internal framework that supports the cell (the cytoskeleton). Merlin also functions as a tumor suppressor protein, which prevents cells from growing and dividing too fast or in an uncontrolled way.

type 2 neurofibromatosis

sporadic mutations - schwannomatosis (like NF2 but no vestibular schwannomas), meningioma, mesothelioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DCC

A

deleted in colorectal carcinoma/cancer

18q21

DCC in a receptor for netrin-1 and is currently believed by some to be a conditional tumour suppressor gene, meaning that it normally prevents cell growth when in the absence of netrin-1. DCC in a receptor for netrin-1 and is currently believed by some to be a conditional tumour suppressor gene, meaning that it normally prevents cell growth when in the absence of netrin-1.

To put this into a biological systems context, some physiology is required. In the gastrointestinal tract, epithelial cells proliferate and die rapidly. The division of these cells occurs at the base of villi, and cells are pushed upwards by subsequent divisions to the tip where they enter apoptosis and shed off into the lumen. Netrin-1 is produced in the base of the villi, so a gradient of netrin is present that is weakest at the tip. In normal physiology, the presence of netrin-1 inhibits DCC-mediated cell death until the epithelial cell reaches the tip of the villus, where the now unbound DCC causes the cell to enter apoptosis. In a cancer state, the absence of DCC prevents the gradient from having an effect on the cell, making it more likely to continue to survive.

also involved in axon and neural crest cell migration in developing fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

WT-1

A

Wilms tumor

11p13

encodes a transcription factor that contains four zinc finger motifs at the C-terminus and a proline / glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a subset of patients with Wilms’ tumor, (sporadic and hereditary) the gene’s namesake.

Desnys-Drash syndrome (gonadal dysgenesis and nephropathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

beta myosin heavy chain

A

chromosome 14

defect in hypertrophic cardiomyopathy (50%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PiSZ

A

Alpha-1 antitrypsin

Others: PiSS, PiMZ

Chromosome 14

“Mmm Mmmm Good” (2 M alleles = good prognosis)

“PiZZ poor” (2 Z alleles = bad prognosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Activated protein C resistance mutations

A
  1. Factor V Leiden: arginine –> glutamine at position 506
  2. Factor V Cambridge: arginine –> threonine at position 306
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prothrombin G20210A Mutation

A

Guanidine to adenine substitution in the 3’
untranslated portion of prothrombin gene on Chr 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EWS gene

A

aka EWSR1 (Ewing sarcoma breakpoint region 1)

22q12.2

ubiquitely expressed & required for cell survival in the central nervous system

Implicated in ES/PNET, DSRCT, myxoid/round cell liposarcoma, clear cell sarcoma of soft parts, angiomatoid fibrous histiocytoma, extraskeletal myxoid chondrosarcoma, rhabdomyosarcoma, giant cell tumor of bone, others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neuroblastoma

A

N-myc = worse prognosis

follow VMA, HVA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pheochromocytoma

A

up to 1/3 of familial pheos have germline mutation in VHL, RET, SDH2

17
Q

STK11

A

(serine/threonine kinase 11)

chromosome 19

Peutz-Jeghers syndrome

18
Q

ETV6-NTKR3

A

gene fusion product detected in paraffin embedded sections in mesoblastic nephroma

19
Q

Follicular thyroid carcinoma

A

PPARY & RAS = independent pathways of follicular carcinogenesis

PPARY: 25-50% of carcinomas but also in some adenomas

N-RAS and H-RAS point mutations in 25-50% of carcinomas

P53 and beta-catenin mutations involved in progression from well-diff to aggressive forms

20
Q

Papillary thyroid carcinoma

A

• RET/PTC overall seen in 20-30% of sporadic adult
papillary ca, but in 45-60% of tumor in children and
young adults and in radiation exposure.
• All RET/PTC formed by fusion of RET (10q11.2) with
other genes on chromosome 10 or on other
chromosomes.
• RET/PTC1: microcarcinomas and classic PTC and
diffuse sclerosing.
• RET/PTC3: most common in children with PTC
developing within 10 yrs of radiation exposure.
Follicular, solid and tall cell patterns
• BRAF mutations seen in up to 70% of PTC and may
cooperate with RET/PTC in carcinogenesis.

21
Q

infiltrating astrocytoma

A

p53 mutations common

associated with NF1, Ollier’s, xeroderma pigementosum, Li-Fraumeni

22
Q

oligodendroglioma

A

loss of chr1p and chr19q

23
Q

Tuberous sclerosis

A

TSC1

9q34

Hamartin

Familial > sporadic

TSC2

16q13.3

Tuberin

Sporadic > familial

24
Q

Medulloblastoma

A

isochromosome 17q (i17q)

chromosome 1 is also frequently involved

MYC amplification = worse prognosis (associated with large cell/anaplastic variant)

Desmoplastic/nodular variant has slightly better prognosis and is assoc with PTCH and SHH pathways

25
Q

BRCA1

A

17q21

assoc with medullary carcinoma (better prognosis than IDC)

26
Q

BRCA2

A

13q12

assoc with male breast carcinoma

27
Q

PTEN

A

10q23.3

Cowden’s syndrome

28
Q

ATM gene

A

11q22-23

ataxia-telangiectasia

29
Q

STK11/LKB1 gene

A

19p13.3

Peutz-Jeghers

30
Q

E-cadherin

A

16q22

LOH at 16q in LCIS

31
Q

INI1

A

SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 is a protein that in humans is encoded by the SMARCB1 gene.

INI-1 is the product of the hSNF5/INI-1/SMARCB-1/BAF47 gene

q22.1

INI-1 is a tumor suppressor involved in ATP-dependent chromatin remodeling, cell cycle control and regulation of the cytoskeleton

rhabdoid tumor of the kidney

renal medullary carcinoma (?)

epithelioid sarcoma

AT/RT (brain)

Loss of nuclear INI-1 expression is the hallmark of pediatric rhabdoid tumors and atypical teratoid/rhabdoid tumors of the central nervous system. Loss of INI-1 expression is seen in >90% of epithelioid sarcomas, but expression is intact in normal tissues and almost all other sarcomas and carcinomas.

32
Q

GNAS1

A

Both syndromic and non-syndromic fibrous dysplasia tumors are associated with GNAS1 mutations. GNAS1 encodes the alpha subunit of stimulatory G-protein.

Most have one bone involved (monostotic) but there may be polyostotic disease as well. Polyostotic fibrous dysplasia can be associated with café au lait spots and endocrinopathies (McCune-Albright syndrome) as well as with intramuscular myxomas (Mazabraud syndrome).